BROADCASTS.com

b'ATLANTA\\u2014Rapid diagnostic tests for malaria promise to distinguish accurately \\u2014 and at low cost \\u2014 patients with fever caused by malaria so that the only patients to receive antimalarial treatment are the ones who truly have the disease. That\\u2019s according to the findings of a symposium held to discuss the use of rapid diagnostic tests and artemisinin-based combination therapy (ACT) at the American Society of Tropical Medicine and Hygiene annual meeting held in Atlanta. Two Principal Investigators and the Director of the ACT Consortium \\u2014 coordinated from the London School of Hygiene and Tropical Medicine \\u2014 were among those taking part: Dr Hugh Reyburn who works in Tanzania, Dr Toby Leslie based in Afghanistan, and the Professor David Schellenberg from London who chaired the discussions. They discuss their findings about the current perceptions and actual use of malaria diagnostics and ACTs in countries where the disease is endemic.'